$WINV
WinVest Acquisition Corp

2022 Q3 Form 10-Q Financial Statement

#000149315222022405 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $252.1K $279.1K $251.8K
YoY Change 280.82% 146025.65% 73955.88%
Operating Profit -$252.1K -$279.1K -$251.8K
YoY Change 280.8% 146025.65%
Interest Expense $523.9K $156.9K $11.70K
YoY Change 327362.5%
% of Operating Profit
Other Income/Expense, Net $523.9K $156.8K $11.70K
YoY Change 323318.52%
Pretax Income $271.9K -$122.3K -$240.1K
YoY Change -511.74% 64242.11% 70517.65%
Income Tax $126.6K
% Of Pretax Income 46.57%
Net Earnings $145.3K -$122.3K -$240.1K
YoY Change -320.0% 63907.33% 71145.7%
Net Earnings / Revenue
Basic Earnings Per Share $0.02 -$0.01 -$0.02
Diluted Earnings Per Share -$0.02 -$0.01 -$16.70K
COMMON SHARES
Basic Shares Outstanding 14.38M shares 11.50M shares 11.50M shares
Diluted Shares Outstanding 2.875M shares 2.875M shares 2.875M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $216.3K $214.2K $307.6K
YoY Change -64.15% 756.64% 1130.44%
Cash & Equivalents $216.2K $214.2K $307.6K
Short-Term Investments
Other Short-Term Assets $392.3K $427.0K $438.1K
YoY Change -0.31%
Inventory
Prepaid Expenses $392.3K $427.0K
Receivables
Other Receivables
Total Short-Term Assets $608.5K $641.2K $745.7K
YoY Change -38.95% 2464.6% 2882.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $116.7M $116.3M $116.2M
YoY Change 0.51%
Other Assets $0.00 $79.78K $177.9K
YoY Change -100.0% -71.18% 131.34%
Total Long-Term Assets $116.7M $116.4M $116.3M
YoY Change 0.19% 41943.25% 151209.92%
TOTAL ASSETS
Total Short-Term Assets $608.5K $641.2K $745.7K
Total Long-Term Assets $116.7M $116.4M $116.3M
Total Assets $117.4M $117.0M $117.1M
YoY Change -0.15% 38673.63% 114816.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $77.00K $50.00K $30.00K
YoY Change -38.51% 20.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $332.6K $168.4K $91.97K
YoY Change 785.3% -39.3% 19.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.025M $4.025M $4.025M
YoY Change 0.0%
Total Long-Term Liabilities $4.025M $4.025M $4.025M
YoY Change 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $332.6K $168.4K $91.97K
Total Long-Term Liabilities $4.025M $4.025M $4.025M
Total Liabilities $4.358M $4.193M $4.117M
YoY Change 7.26% 1411.73% 5230.79%
SHAREHOLDERS EQUITY
Retained Earnings -$3.698M -$3.370M
YoY Change
Common Stock $288.00 $288.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.698M -$3.369M -$3.179M
YoY Change
Total Liabilities & Shareholders Equity $117.4M $117.0M $117.1M
YoY Change -0.15% 38673.63% 114816.02%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $145.3K -$122.3K -$240.1K
YoY Change -320.0% 63907.33% 71145.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$99.94K -$93.45K -$200.3K
YoY Change -87.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $102.0K $0.00 $0.00
YoY Change -100.09%
Cash From Investing Activities $102.0K $0.00 $0.00
YoY Change -100.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -99.94K -93.45K -200.3K
Cash From Investing Activities 102.0K 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash 2.090K -93.45K $0.00
YoY Change -99.64%
FREE CASH FLOW
Cash From Operating Activities -$99.94K -$93.45K -$200.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001854463
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
usd
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
WINV Formation Costs Paid By Thirdparty
FormationCostsPaidByThirdparty
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
WINV Deferred Offering Cost
DeferredOfferingCost
usd
WINV Common Stock Issued For Relief Of Related Party Advances
CommonStockIssuedForReliefOfRelatedPartyAdvances
usd
WINV Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40796
dei Entity Registrant Name
EntityRegistrantName
WINVEST ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2451181
dei Entity Address Address Line1
EntityAddressAddressLine1
125 Cambridgepark Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 301
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02140
dei City Area Code
CityAreaCode
(617)
dei Local Phone Number
LocalPhoneNumber
658-3094
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14375000 shares
CY2022Q2 us-gaap Cash
Cash
214155 usd
CY2021Q4 us-gaap Cash
Cash
507906 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
426996 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
393500 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
641151 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
901406 usd
CY2022Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
79779 usd
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
276797 usd
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
116321157 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
116152616 usd
CY2022Q2 us-gaap Assets
Assets
117042087 usd
CY2021Q4 us-gaap Assets
Assets
117330819 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
118380 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
94760 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
50000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
168380 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
94760 usd
CY2022Q2 WINV Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
4025000 usd
CY2021Q4 WINV Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
4025000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
4193380 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4119760 usd
CY2022Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11500000 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11500000 shares
CY2022Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.11
CY2021Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.10
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
116218086 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
116150000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2875000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2875000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2875000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2875000 shares
CY2022Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11500000 shares
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11500000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
288 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
288 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3369667 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2939229 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3369379 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2938941 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117042087 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
117330819 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
279100 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
191 usd
us-gaap Operating Expenses
OperatingExpenses
530894 usd
us-gaap Operating Expenses
OperatingExpenses
528 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-279100 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-191 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-530894 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-528 usd
CY2022Q2 us-gaap Interest Income Other
InterestIncomeOther
156846 usd
us-gaap Interest Income Other
InterestIncomeOther
168542 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156846 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
168542 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-122254 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-191 usd
us-gaap Net Income Loss
NetIncomeLoss
-362352 usd
us-gaap Net Income Loss
NetIncomeLoss
-528 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2875000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2875000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2500000 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-337 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
24663 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-191 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
24472 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2938941 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-240098 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3179039 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
68086 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-122254 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3369379 usd
us-gaap Net Income Loss
NetIncomeLoss
-362352 usd
us-gaap Net Income Loss
NetIncomeLoss
-528 usd
us-gaap Interest Income Other
InterestIncomeOther
168542 usd
WINV Formation Costs Paid By Thirdparty
FormationCostsPaidByThirdparty
337 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-163522 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23621 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
191 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
50000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-293751 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-293751 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
507906 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
214155 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25000 usd
WINV Deferred Offering Cost
DeferredOfferingCost
199966 usd
WINV Common Stock Issued For Relief Of Related Party Advances
CommonStockIssuedForReliefOfRelatedPartyAdvances
25000 usd
WINV Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
68086 usd
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000000 usd
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
WINV Percentage Of Deferred Underwriting Discounts And Commissions Payable To Underwriters
PercentageOfDeferredUnderwritingDiscountsAndCommissionsPayableToUnderwriters
0.035 pure
us-gaap Interest Paid Net
InterestPaidNet
100000 usd
CY2022Q2 us-gaap Cash
Cash
214155 usd
CY2022Q2 WINV Working Capital
WorkingCapital
472771 usd
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_zL0vqEhpNi54" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zsl5Ss7lErdh">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-191 usd
us-gaap Net Income Loss
NetIncomeLoss
-528 usd
CY2021Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
116150000 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2923969 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
2400000 usd
CY2022Q2 WINV Deferred Underwriting Commissions
DeferredUnderwritingCommissions
4025000 usd
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2500000 shares
WINV Change In Value Of Common Stock Subject To Possible Redemption Shares
ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares
11966667 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zJZPhGidUU4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_z8TKCYdLUuec">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_901_eus-gaap--CashFDICInsuredAmount_iI_c20220630_zSyQSJkKIGth" title="Cash FDIC insured amount">250,000</span>. As of June 30, 2022, the Company has not experienced losses on this account. Additionally, the Company maintains cash balances with major financial institutions. Accordingly, the Company does not believe it is exposed to significant risks on such amounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2021Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
300000 usd
CY2021Q1 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
0.50
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
us-gaap Professional Fees
ProfessionalFees
10000 usd
CY2022Q2 WINV Recognized Expenses
RecognizedExpenses
30000 usd
WINV Recognized Expenses
RecognizedExpenses
60000 usd
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
116321157 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
116152616 usd
CY2022Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-152272 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-344350 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11500000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q2 WINV Net Loss Applicable To Nonredeemable Common Shares Including Accretion Of Temporary Equity
NetLossApplicableToNonredeemableCommonSharesIncludingAccretionOfTemporaryEquity
-38068 usd
WINV Net Loss Applicable To Nonredeemable Common Shares Including Accretion Of Temporary Equity
NetLossApplicableToNonredeemableCommonSharesIncludingAccretionOfTemporaryEquity
-86088 usd
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2875000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2875000 shares
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
50000 usd
CY2021 WINV Common Shares Subject Possible Redemption Gross Proceeds
CommonSharesSubjectPossibleRedemptionGrossProceeds
115000000 usd
CY2021 WINV Offering Costs Allocated To Common Stock Subject To Possible Redemption
OfferingCostsAllocatedToCommonStockSubjectToPossibleRedemption
-6498541 usd
CY2021 WINV Proceeds From Issuance Of Public Warrants
ProceedsFromIssuanceOfPublicWarrants
2357500 usd
CY2021 WINV Deposit To Trust Account From Private Placement
DepositToTrustAccountFromPrivatePlacement
1150000 usd
CY2021 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
8856041 usd
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
116150000 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
68086 usd
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
116218086 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.273 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.273 pure

Files In Submission

Name View Source Status
0001493152-22-022405-index-headers.html Edgar Link pending
0001493152-22-022405-index.html Edgar Link pending
0001493152-22-022405.txt Edgar Link pending
0001493152-22-022405-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
winv-20220630.xsd Edgar Link pending
winv-20220630_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
winv-20220630_pre.xml Edgar Link unprocessable
winv-20220630_lab.xml Edgar Link unprocessable
winv-20220630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable